EGFR mutations and sensitivity to gefitinib. [N Engl J Med. 2004] - PubMed

Save items

loading

Related citations in PubMed

EGFR mutations and sensitivity to gefitinib. [N Engl J Med. 2004]
EGFR mutations and sensitivity to gefitinib.
Rossi G, Marchioni A, Longo L. N Engl J Med. 2004 Sep 16; 351(12):1260-1; author reply 1260-1.
Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation. [Lung Cancer. 2005]
Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation.
Taja-Chayeb L, Candelaria M, Brom R, Trejo-Becerril C, Meza F, Duenas-Gonzalez A. Lung Cancer. 2005 Nov; 50(2):259-63. Epub 2005 Jul 11.
Mutations in the epidermal growth factor receptor tyrosine kinase may predict response to gefitinib in non-small-cell lung cancer. [Clin Lung Cancer. 2004]
Mutations in the epidermal growth factor receptor tyrosine kinase may predict response to gefitinib in non-small-cell lung cancer.
. Clin Lung Cancer. 2004 May; 5(6):331-2.
Review Clinical development of gefitinib in non-small-cell lung cancer and the Iressa Survival Evaluation in Lung Cancer trial. [Clin Lung Cancer. 2005]
Review Clinical development of gefitinib in non-small-cell lung cancer and the Iressa Survival Evaluation in Lung Cancer trial.
Price N, Belani C. Clin Lung Cancer. 2005 Jan; 6(4):214-6.
Review [Tumor response to gefitinib (IRESSA) in pulmonary adenocarcinoma: toward a molecular basis for therapeutic targetting]. [Rev Mal Respir. 2004]
Review [Tumor response to gefitinib (IRESSA) in pulmonary adenocarcinoma: toward a molecular basis for therapeutic targetting].
Madelaine J, Cadranel J, Zalcman G. Rev Mal Respir. 2004 Nov; 21(5 Pt 1):881-5.

See reviews... See all...

Cited by 3 PubMed Central articles

Review Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics. [Mol Cancer. 2010]
Review Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.
Krakstad C, Chekenya M. Mol Cancer. 2010 Jun 1; 9:135. Epub 2010 Jun 1.
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma. [Clin Cancer Res. 2009]
Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.
Broniscer A, Baker SJ, Stewart CF, Merchant TE, Laningham FH, Schaiquevich P, Kocak M, Morris EB, Endersby R, Ellison DW, et al. Clin Cancer Res. 2009 Jan 15; 15(2):701-7.
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. [PLoS Med. 2006]
Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain.
Lee JC, Vivanco I, Beroukhim R, Huang JH, Feng WL, DeBiasi RM, Yoshimoto K, King JC, Nghiemphu P, Yuza Y, et al. PLoS Med. 2006 Dec; 3(12):e485.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

EGFR mutations and sensitivity to gefitinib.
EGFR mutations and sensitivity to gefitinib.
N Engl J Med. 2004 Sep 16 ;351(12):1260-1; author reply 1260-1.

PubMed
Self-organization of vertebrate mesoderm based on simple boundary conditions.
Self-organization of vertebrate mesoderm based on simple boundary conditions.
Dev Dyn. 2004 Nov ;231(3):576-81.

PubMed
Morphometric index of the developing murine kidney.
Morphometric index of the developing murine kidney.
Dev Dyn. 2004 Nov ;231(3):601-8.

PubMed
Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
J Pathol. 2004 Oct ;204(2):140-6.

PubMed
Effects of exercise training and detraining on oxidized low-density lipoprotein-...
Effects of exercise training and detraining on oxidized low-density lipoprotein-potentiated platelet function in men.
Arch Phys Med Rehabil. 2004 Sep ;85(9):1531-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

EGFR mutations and sensitivity to gefitinib.

Comment on

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information